| Literature DB >> 32644981 |
Heather E Hsu, Erin M Ashe, Michael Silverstein, Melissa Hofman, Samantha J Lange, Hilda Razzaghi, Rebecca G Mishuris, Ravin Davidoff, Erin M Parker, Ana Penman-Aguilar, Kristie E N Clarke, Anna Goldman, Thea L James, Karen Jacobson, Karen E Lasser, Ziming Xuan, Georgina Peacock, Nicole F Dowling, Alyson B Goodman.
Abstract
As of July 5, 2020, approximately 2.8 million coronavirus disease 2019 (COVID-19) cases and 130,000 COVID-19-associated deaths had been reported in the United States (1). Populations historically affected by health disparities, including certain racial and ethnic minority populations, have been disproportionally affected by and hospitalized with COVID-19 (2-4). Data also suggest a higher prevalence of infection with SARS-CoV-2, the virus that causes COVID-19, among persons experiencing homelessness (5). Safety-net hospitals,† such as Boston Medical Center (BMC), which provide health care to persons regardless of their insurance status or ability to pay, treat higher proportions of these populations and might experience challenges during the COVID-19 pandemic. This report describes the characteristics and clinical outcomes of adult patients with laboratory-confirmed COVID-19 treated at BMC during March 1-May 18, 2020. During this time, 2,729 patients with SARS-CoV-2 infection were treated at BMC and categorized into one of the following mutually exclusive clinical severity designations: exclusive outpatient management (1,543; 56.5%), non-intensive care unit (ICU) hospitalization (900; 33.0%), ICU hospitalization without invasive mechanical ventilation (69; 2.5%), ICU hospitalization with mechanical ventilation (119; 4.4%), and death (98; 3.6%). The cohort comprised 44.6% non-Hispanic black (black) patients and 30.1% Hispanic or Latino (Hispanic) patients. Persons experiencing homelessness accounted for 16.4% of patients. Most patients who died were aged ≥60 years (81.6%). Clinical severity differed by age, race/ethnicity, underlying medical conditions, and homelessness. A higher proportion of Hispanic patients were hospitalized (46.5%) than were black (39.5%) or non-Hispanic white (white) (34.4%) patients, a finding most pronounced among those aged <60 years. A higher proportion of non-ICU inpatients were experiencing homelessness (24.3%), compared with homeless patients who were admitted to the ICU without mechanical ventilation (15.9%), with mechanical ventilation (15.1%), or who died (15.3%). Patient characteristics associated with illness and clinical severity, such as age, race/ethnicity, homelessness, and underlying medical conditions can inform tailored strategies that might improve outcomes and mitigate strain on the health care system from COVID-19.Entities:
Mesh:
Year: 2020 PMID: 32644981 PMCID: PMC7727597 DOI: 10.15585/mmwr.mm6927a3
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Clinical characteristics of patients with COVID-19 (N = 2,729) — Boston Medical Center, March 1–May 18, 2020
| Characteristic† | Total
(N = 2,729) | Mutually exclusive clinical severity categories | ||||
|---|---|---|---|---|---|---|
| Outpatient management
(n = 1,543) | Inpatient hospitalization* | Deceased | ||||
| Non-ICU (n = 900) | ICU without mechanical ventilation (n = 69) | ICU with mechanical ventilation (n = 119) | ||||
| No. (%) | ||||||
|
| ||||||
| 18–29 |
| 244 (15.8) | 53 (5.9) | 3 (4.3) | 9 (7.6) | 0 (—) |
| 30–39 |
| 325 (21.1) | 125 (13.9) | 6 (8.7) | 11 (9.2) | 5 (5.1) |
| 40–49 |
| 322 (20.9) | 149 (16.6) | 9 (13.0) | 17 (14.3) | 6 (6.1) |
| 50–59 |
| 281 (18.2) | 187 (20.8) | 14 (20.3) | 28 (23.5) | 7 (7.1) |
| 60–69 |
| 207 (13.4) | 176 (19.6) | 17 (24.6) | 30 (25.2) | 30 (30.6) |
| 70–79 |
| 82 (5.3) | 126 (14.0) | 11 (15.9) | 19 (16.0) | 20 (20.4) |
| ≥80 |
| 82 (5.3) | 84 (9.3) | 9 (13.0) | 5 (4.2) | 30 (30.6) |
|
| ||||||
| Female |
| 896 (58.1) | 428 (47.6) | 21 (30.4) | 40 (33.6) | 32 (32.7) |
| Male |
| 647 (41.9) | 472 (52.4) | 48 (69.6) | 79 (66.4) | 66 (67.3) |
|
| ||||||
| Black, non-Hispanic |
| 689 (44.7) | 399 (44.3) | 32 (46.4) | 50 (42.0) | 48 (49.0) |
| Hispanic or Latino |
| 421 (27.3) | 320 (35.6) | 19 (27.5) | 43 (36.1) | 18 (18.4) |
| White, non-Hispanic |
| 221 (14.3) | 101 (11.2) | 10 (14.5) | 16 (13.4) | 21 (21.4) |
| Other race, non-Hispanic¶ |
| 60 (3.9) | 17 (1.9) | 2 (2.9) | 2 (1.7) | 3 (3.1) |
| Unknown/Declined |
| 152 (9.9) | 63 (7.0) | 6 (8.7) | 8 (6.7) | 8 (8.2) |
|
| ||||||
| Asthma |
| 176 (11.4) | 140 (15.6) | 6 (8.7) | 23 (19.3) | 15 (15.3) |
| Cancer |
| 67 (4.3) | 90 (10.0) | 10 (14.5) | 10 (8.4) | 18 (18.4) |
| Chronic kidney disease |
| 115 (7.5) | 149 (16.6) | 13 (18.8) | 20 (16.8) | 35 (35.7) |
| Chronic kidney disease on dialysis |
| 31 (2.0) | 53 (5.9) | 5 (7.2) | 8 (6.7) | 9 (9.2) |
| Cirrhosis |
| 17 (1.1) | 16 (1.8) | 2 (2.9) | 3 (2.5) | 4 (4.1) |
| Congestive heart failure |
| 59 (3.8) | 106 (11.8) | 8 (11.6) | 11 (9.2) | 32 (32.7) |
| Chronic obstructive pulmonary disease |
| 35 (2.3) | 78 (8.7) | 6 (8.7) | 11 (9.2) | 16 (16.3) |
| Coronary artery disease |
| 71 (4.6) | 73 (8.1) | 6 (8.7) | 10 (8.4) | 30 (30.6) |
| Diabetes |
| 274 (17.8) | 317 (35.2) | 24 (34.8) | 47 (39.5) | 46 (46.9) |
| HIV/AIDS |
| 36 (2.3) | 31 (3.4) | 2 (2.9) | 2 (1.7) | 2 (2.0) |
| Hypertension |
| 556 (36.0) | 516 (57.3) | 39 (56.5) | 66 (55.5) | 71 (72.4) |
| Obesity (BMI >30 kg/m2) |
| 553 (35.8) | 465 (51.7) | 31 (44.9) | 69 (58.0) | 46 (46.9) |
| Serious mental illness |
| 87 (5.6) | 103 (11.4) | 7 (10.1) | 13 (10.9) | 9 (9.2) |
| Sickle cell disease |
| 5 (0.3) | 8 (0.9) | 0 (—) | 1 (0.8) | 1 (1.0) |
| Substance use disorder |
| 161 (10.4) | 178 (19.8) | 14 (20.3) | 24 (20.2) | 19 (19.4) |
| ≥1 of above conditions |
| 977 (63.3) | 799 (88.8) | 57 (82.6) | 111 (93.3) | 89 (90.8) |
| ≥2 of above conditions |
| 606 (39.3) | 613 (68.1) | 44 (63.8) | 89 (74.8) | 77 (78.6) |
|
| ||||||
| Homelessness |
| 184 (11.9) | 219 (24.3) | 11 (15.9) | 18 (15.1) | 15 (15.3) |
| Residing in nursing home |
| 114 (7.4) | 44 (4.9) | 6 (8.7) | 7 (5.9) | 10 (10.2) |
|
|
| 42 (2.7) | 42 (4.7) | 1 (1.4) | 4 (3.4) | 0 (—) |
Abbreviations: AIDS = acquired immunodeficiency syndrome; BMI = body mass index; COVID-19 = coronavirus disease 2019; HIV = human immunodeficiency virus; ICU = intensive care unit.
* Survived.
† Patient characteristics are not mutually exclusive; therefore, the counts and proportions might not sum to the totals.
§ Of the 98 patients who died, all had been hospitalized, including 27 (27.6%) who received non-ICU inpatient care, 15 (15.3%) who received ICU care without mechanical ventilation, and 56 (57.1%) who received ICU care with mechanical ventilation
¶ Other race included persons who identified as Asian, American Indian, Middle Eastern, Native Hawaiian/Pacific Islander. These groups were consolidated due to small numbers.
** Underlying medical conditions were defined using International Classification of Diseases, Tenth Revision codes from patients’ active condition lists or encounter diagnoses within the electronic health record. Obesity was defined by BMI ≥30 kg/m2. Patients with substance use disorder were additionally identified via presence of orders for inpatient assessment of opiate or alcohol withdrawal symptoms, inpatient consult to an addiction medicine service, or encounters for previous outpatient substance use disorder treatment.
†† Homelessness was identified by a registration screening question, use of an inpatient homeless discharge planning service, or registration address listed as a known homeless shelter. Nursing home residence was identified by cross-referencing a list of known nursing home patients or matching registration address with known nursing home addresses.
§§ Patients were categorized as pregnant if a health care encounter for COVID-19 occurred before, or up to 7 days after, the end of pregnancy.
Characteristics of patients with COVID-19 by race/ethnicity (N = 2,729) — Boston Medical Center, March 1–May 18, 2020
| Characteristics* | Race/Ethnicity | |||||
|---|---|---|---|---|---|---|
| Total
(N = 2,729) | Black, non-Hispanic
(n = 1,218) | Hispanic/Latino
(n = 821) | White, non-Hispanic
(n = 369) | Other race, non-Hispanic†
(n = 84) | Unknown/Declined (n= 237) | |
| No. (%) | ||||||
|
| ||||||
| 18–29 |
| 106 (8.7) | 129 (15.7) | 26 (7.0) | 13 (15.5) | 35 (14.8) |
| 30–39 |
| 198 (16.3) | 152 (18.5) | 67 (18.2) | 13 (15.5) | 42 (17.7) |
| 40–49 |
| 213 (17.5) | 190 (23.1) | 46 (12.5) | 15 (17.9) | 39 (16.5) |
| 50–59 |
| 223 (18.3) | 165 (20.1) | 66 (17.9) | 15 (17.9) | 48 (20.3) |
| 60–69 |
| 232 (19.0) | 112 (13.6) | 69 (18.7) | 10 (11.9) | 37 (15.6) |
| 70–79 |
| 137 (11.2) | 46 (5.6) | 47 (12.7) | 8 (9.5) | 20 (8.4) |
| ≥80 |
| 109 (8.9) | 27 (3.3) | 48 (13.0) | 10 (11.9) | 16 (6.8) |
|
| ||||||
| Female |
| 657 (53.9) | 389 (47.4) | 185 (50.1) | 49 (57.1) | 137 (57.8) |
| Male |
| 561 (46.1) | 432 (52.6) | 184 (49.9) | 35 (41.7) | 100 (42.2) |
|
| ||||||
| Asthma |
| 188 (15.4) | 102 (12.4) | 43 (11.7) | 6 (7.1) | 21 (8.9) |
| Cancer |
| 106 (8.7) | 43 (5.2) | 31 (8.4) | 4 (4.8) | 11 (4.6) |
| Chronic kidney disease |
| 222 (18.2) | 55 (6.7) | 34 (9.2) | 7 (8.3) | 14 (5.9) |
| Chronic kidney disease on dialysis |
| 64 (5.3) | 22 (2.7) | 10 (2.7) | 3 (3.6) | 7 (3.0) |
| Cirrhosis |
| 20 (1.6) | 10 (1.2) | 8 (2.2) | 0 (0.0) | 4 (1.7) |
| Congestive heart failure |
| 129 (10.6) | 32 (3.9) | 44 (11.9) | 3 (3.6) | 8 (3.4) |
| Chronic obstructive pulmonary disease |
| 70 (5.7) | 16 (1.9) | 47 (12.7) | 4 (4.8) | 9 (3.8) |
| Coronary artery disease |
| 104 (8.5) | 35 (4.3) | 40 (10.8) | 2 (2.4) | 9 (3.8) |
| Diabetes mellitus |
| 382 (31.4) | 196 (23.9) | 53 (14.4) | 21 (25.0) | 56 (23.6) |
| HIV/AIDS |
| 47 (3.9) | 11 (1.3) | 8 (2.2) | 0 (0.0) | 7 (3.0) |
| Hypertension |
| 686 (56.3) | 292 (35.6) | 149 (40.4) | 28 (33.3) | 93 (39.2) |
| Obesity (BMI ≥30 kg/m2) |
| 576 (47.3) | 388 (47.3) | 102 (27.6) | 11 (13.1) | 87 (36.7) |
| Serious mental illness |
| 89 (7.3) | 57 (6.9) | 59 (16.0) | 8 (9.5) | 6 (2.5) |
| Sickle cell disease |
| 11 (0.9) | 3 (0.4) | 0 (0.0) | 0 (0.0) | 1 (0.4) |
| Substance use disorder |
| 171 (14.0) | 98 (11.9) | 105 (28.5) | 8 (9.5) | 14 (5.9) |
| ≥1 of above conditions |
| 983 (80.7) | 602 (73.3) | 258 (69.9) | 43 (51.2) | 147 (62.0) |
| ≥2 of above conditions |
| 745 (61.2) | 366 (44.6) | 193 (52.3) | 30 (35.7) | 95 (40.1) |
|
| ||||||
| Homelessness |
| 203 (16.7) | 100 (12.2) | 110 (29.8) | 11 (13.1) | 23 (9.7) |
| Residing in nursing home |
| 101 (8.3) | 14 (1.7) | 51 (13.8) | 11 (13.1) | 4 (1.7) |
|
|
| 30 (2.5) | 49 (6.0) | 4 (1.1) | 2 (2.4) | 4 (1.7) |
Abbreviations: AIDS = acquired immunodeficiency syndrome; BMI = body mass index; COVID-19 = coronavirus disease 2019; HIV = human immunodeficiency virus.
* Patient characteristics are not mutually exclusive; therefore, the counts and proportions might not sum to totals.
† Other race included persons who identified as Asian, American Indian, Middle Eastern, Native Hawaiian/Pacific Islander. These groups were consolidated because of small numbers.
§ Underlying medical conditions were defined using International Classification of Diseases, Tenth Revision codes from patients’ active condition lists or encounter diagnoses within the electronic health record. Obesity was defined by BMI ≥30 kg/m2. Patients with substance use disorder were additionally identified via presence of orders for inpatient assessment of opiate or alcohol withdrawal symptoms, inpatient consult to an addiction medicine service, or encounters for previous outpatient substance use disorder treatment.
¶ Homelessness was identified by a registration screening question, use of an inpatient homeless discharge planning service, or registration address listed as a known homeless shelter. Nursing home residence was identified by cross-referencing a list of known nursing home patients or matching registration address with known nursing home addresses.
** Patients were categorized as pregnant if a health care encounter for COVID-19 occurred before, or up to 7 days after, the end of pregnancy.
FIGUREClinical severity of illness in patients* with COVID-19, by age and race/ethnicity (N = 2,729) — Boston Medical Center, March 1–May 18, 2020
Abbreviation: COVID-19 = coronavirus disease 2019.
* Inpatients include surviving patients whose highest level of care included non–intensive care unit hospitalization or intensive care unit hospitalization with or without invasive mechanical ventilation.